Sotorasib, a tablet form of oral medication is used in the treatment and management of non- small cell lung cancer, also referred as NSCLC. This FDA and EMA approved medication would be of great relevance for cancer patients across the world. This is specifically recommended for patients with KRAS G12C mutation. It is natural for such products to grow in demand when there are limited options available in specific treatment settings. Lumakras 120 mg tablets are commercially available in the western markets. It is a product of Amgen Inc. Sotorasib cost in India will be determined based on the global factors.
Lumakras (Sotorasib) 120 mg Tablets – US FDA and EMA Approval
Sotorasib is the first drug that targets G12C KRAS mutation. It is significant as this mutation is known to be seen in 14% of non-small-cell lung cancer adenocarcinoma patients. Apart from NSCLC, G12C KRAS mutation is seen in patients with colorectal cancer as well. This indicates the scope of expanding the use of Sotorasib in the future. Lumakras (Sotorasib) received its US FDA approval in May 2021. It has received the EU EMA approval in January 2022.
- Lumakras 120 mg tablets are specifically recommended in patients who progressed after systemic treatment. Because of the limitation of conventional treatments, advanced options that target specific mutations have the advantage. Sotorasib was granted breakthrough designation by the FDA.
- Patients are advised for this medication after confirming their suitability. It has received accelerated approval based on Overall Response Rate in patients participated in the clinical research. Sotorasib is regarded as a key development in cancer research.
Buy Sotorasib in India through legal sourcing process
Understanding the ideal Lumakras price in India would help in assessing the overall treatment costing. In order to get the accurate pricing information, it is important to know the treatment recommendations in terms of the dosage and quantity of medicines. Global procurement companies operate based on the legal framework of the respective countries. Legally importing products like Sotorasib is recommended in order to ensure genuineness of the product. Not all patients may be the ideal candidates for certain lifesaving medicines. The suitability or eligibility is based on the physician’s assessment. There are several factors that impact the cost of Lumakras (Sotorasib). Forex variations often play an important role in the cost different from one country to another country. The ease of accessing a particular medicine would also impact the cost. If there are stock shortages and similar limitations, it may also impact Sotorasib price in India. Patients may come across unauthorized suppliers giving attractive prices and discounts. There needs be more caution from the patients’ end while dealing with such suppliers or sources.
Reliable procurement of Trodelvy (Sacituzumab govitecan)
It may look complex for patients when they are considering to source and buy certain products unavailable in India. A lot of the procedures can be completed through online forms and applications. If all the necessary documents are available, it is not very difficult to apply and secure import permits from CDSCO. It is the Indian agency that has the authorization to issue permits in limited quantities for specialized products. Importing Sotorasib in limited quantities require the assistance of companies with access to international medications. Patients can confidently engage licensed providers to ensure hassle-free procurement.
Contact Noel Biotech – +91 9677010046 / +91 992977766; email@example.com